Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stockholm - Delayed Quote SEK

Acuvi AB (ACUVI.ST)

14.36
-0.22
(-1.51%)
At close: April 25 at 5:22:47 PM GMT+2
Loading Chart for ACUVI.ST
  • Previous Close 14.58
  • Open 14.60
  • Bid 14.36 x --
  • Ask 14.54 x --
  • Day's Range 14.16 - 14.90
  • 52 Week Range 10.68 - 18.70
  • Volume 25,189
  • Avg. Volume 33,900
  • Market Cap (intraday) 429.842M
  • Beta (5Y Monthly) 1.04
  • PE Ratio (TTM) 11.97
  • EPS (TTM) 1.20
  • Earnings Date Apr 24, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 11, 2017
  • 1y Target Est --

Acuvi AB provides components and systems solutions for motion and positioning in Sweden and internationally. The company provides solutions in the field of life science instrumentation, semicon, medtech, and advanced industrial. Its products are primarily used in advanced microscopy and imaging, microfluids, semiconductor, manufacturing, and advanced optics. The company was formerly known as PiezoMotor Uppsala AB (publ) and changed its name to Acuvi AB in April 2022. Acuvi AB was incorporated in 1997 and is headquartered in Uppsala, Sweden.

www.acuvi.com

53

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ACUVI.ST

View More

Performance Overview: ACUVI.ST

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

ACUVI.ST
11.36%
OMX Stockholm 30 Index (^OMX)
2.26%

1-Year Return

ACUVI.ST
35.47%
OMX Stockholm 30 Index (^OMX)
3.90%

3-Year Return

ACUVI.ST
63.55%
OMX Stockholm 30 Index (^OMX)
18.35%

5-Year Return

ACUVI.ST
44.98%
OMX Stockholm 30 Index (^OMX)
60.29%

Compare To: ACUVI.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACUVI.ST

View More

Valuation Measures

Annual
As of 4/25/2025
  • Market Cap

    423.36M

  • Enterprise Value

    477.35M

  • Trailing P/E

    11.97

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.22

  • Price/Book (mrq)

    0.96

  • Enterprise Value/Revenue

    2.68

  • Enterprise Value/EBITDA

    9.18

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    18.74%

  • Return on Assets (ttm)

    3.22%

  • Return on Equity (ttm)

    9.41%

  • Revenue (ttm)

    178.22M

  • Net Income Avi to Common (ttm)

    33.4M

  • Diluted EPS (ttm)

    1.20

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    20.98M

  • Total Debt/Equity (mrq)

    17.00%

  • Levered Free Cash Flow (ttm)

    2.51M

Research Analysis: ACUVI.ST

View More

Company Insights: ACUVI.ST

Research Reports: ACUVI.ST

View More

People Also Watch